The Fed. Circ. In June: More Liability For Generic-Drug Makers
This article is part of a monthly column that highlights an important patent appeal from the previous month. In this installment, we examine Amarin v. Hikma and what it means for how generic...To view the full article, register now.
Already a subscriber? Click here to view full article